NovaBay Pharmaceuticals Inc (NYSE American:NBY)

3.31
Delayed Data
As of 11:49am ET
 -0.024 / -0.72%
Today’s Change
2.25
Today|||52-Week Range
5.00
-14.03%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close3.33
Today’s open3.35
Day’s range3.31 - 3.35
Volume1,394
Average volume (3 months)10,432
Market cap$49.2M
Data as of 11:49am ET, 04/23/2018

Growth & Valuation

Earnings growth (last year)+79.47%
Earnings growth (this year)+59.05%
Earnings growth (next 5 years)--
Revenue growth (last year)+171.56%
P/E ratioNM
Price/Sales2.61
Price/Book6.88

Competitors

 Today’s
change
Today’s
% change
EIGREiger BioPharmaceuti...-0.35-3.40%
SPHSSophiris Bio Inc-0.02-0.81%
RNNRexahn Pharmaceutica...-0.07-4.24%
LIFEaTyr Pharma Inc-0.05-2.08%
Data as of 4:10pm ET, 04/23/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$11.9M
Annual profit (last year)-$13.2M
Net profit margin-110.54%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
Chief Financial Officer
John J. McGovern
Corporate headquarters
Emeryville, California

Forecasts